January 6, 2022Open Access

Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

Key Points

Key points are not available for this paper at this time.

Abstract

Pembrolizumab demonstrated robust and durable antitumor activity and encouraging survival outcomes with manageable toxicity in patients with previously treated, advanced MSI-H/dMMR endometrial cancer.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

David M. O’Malley

Giovanni M. Bariani

Philippe A. Cassier

Journals

Journal of Clinical Oncology

Actions

Institutions

Inserm

McGill University

The University of Melbourne

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study